The 7th Summit on Tobacco Harm Reduction: Novel products, Research & Policy, is organized by SCOHRE, the International Association on Smoking Control & Harm Reduction, on the 16th and 17th September 2024, this time only virtually.

The scientific Summit aims to attract top researchers, clinicians, and scientists from diverse fields, from all over the world, to present and discuss their work and participate in a constructive dialogue to help come up with a better approach to the global burden of smoking.

This is the second consecutive year that SCOHRE address an open Call for Speakers to tobacco harm reduction and tobacco control experts or advocates; basic or medical science researchers, or scientists in other related fields, to express their interest in participating in the 7th Summit.

SCOHRE recognize that harm reduction could make the lives of people better and invite scientists from multiple fields to present basic research and clinical evidence, thus contributing to the discussion that leads to “evidence-based policymaking” and fights misinformation.

In previous Summits it was established that, during the last 30 years, the prevalence of smoking has decreased steadily around the globe. However, as populations have grown, the total number of smokers has increased. There is increasing interest in Tobacco Harm Reduction as a tool to reduce the detrimental consequences of cigarette smoking to the human population of the planet. However, more data is needed for politicians and public health regulators to make informed decisions.

All these and many more will be discussed in the two-day event on THR.

The objectives of the Summit are to offer opportunities for scientists of different countries to:

  • Present, discuss, and challenge recent data related to the benefits and the risks associated with alternative tobacco product use among smokers and the association with switch and quit attempts.
  • Discuss and debate on scientific, technological, medical, regulatory, legal and policy issues for advancing the technical capacity of the participating countries.
  • Provide an environment where regulatory authorities and policy makers may present to the scientific and medical communities their prospective course of action.

The scientific programme of the Summit will include plenary and keynote lectures, as well as oral and e-poster presentations, on the following specific topics:

Toxicology and aerosol chemistry || Biomarkers’ evaluation in animal or human studies || Preclinical evaluation || Epidemiology & Social Issues || Clinical Assessment and Harm Reduction || Public Health || Legal & Regulatory issues || Bioethics || Innovation & Novel Products || Smoking cessation || Educational issues in adolescence